Keyphrases
Long-term Survival
100%
Percutaneous Coronary Intervention
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Non-diabetic
100%
Diabetic
81%
Stent
36%
Glycoprotein IIb/IIIa Inhibitors
36%
Diabetic Patients
27%
Coronary Disease
18%
Hypertension
9%
Intervention Techniques
9%
Diabetes
9%
Renal Failure
9%
Stable Angina
9%
Consecutive Patients
9%
Congestive Heart Failure
9%
Active Smoking
9%
Hospital Discharge
9%
Baseline Characteristics
9%
All-cause Mortality
9%
Renal Insufficiency
9%
Percutaneous Transluminal Coronary Angioplasty
9%
Late Mortality
9%
Dialysis
9%
Platelet Glycoproteins
9%
Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Long Term Survival
100%
Diabetes Mellitus
100%
Glycoprotein IIb/IIIa Inhibitors
27%
Coronary Artery Disease
18%
Renal Failure
18%
Platelet Glycoprotein IIb/IIIa
18%
Diabetes
9%
Unstable Angina Pectoris
9%
Congestive Heart Failure
9%
Transluminal Coronary Angioplasty
9%
All Cause Mortality
9%
Fibrinogen Receptor Antagonist
9%
Pharmacology, Toxicology and Pharmaceutical Science
Long Term Survival
100%
Diabetes Mellitus
100%
Fibrinogen Receptor
27%
Coronary Artery Disease
18%
Kidney Failure
18%
Unstable Angina Pectoris
9%
Congestive Heart Failure
9%
All Cause Mortality
9%
Fibrinogen Receptor Antagonist
9%
Hypertension
9%